DELTA 9 CANNABIS INC (DN.CA) Stock Price & Overview
TSX:DN • CA2477541049
Current stock price
The current stock price of DN.CA is 0.01 CAD. Today DN.CA is down by 0%. In the past month the price decreased by -33.33%. In the past year, price decreased by -84.62%.
DN.CA Key Statistics
- Market Cap
- 1.872M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.10
- Dividend Yield
- N/A
DN.CA Stock Performance
DN.CA Stock Chart
DN.CA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to DN.CA. When comparing the yearly performance of all stocks, DN.CA is a bad performer in the overall market: 99.23% of all stocks are doing better.
DN.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to DN.CA. DN.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
DN.CA Earnings
DN.CA Forecast & Estimates
8 analysts have analysed DN.CA and the average price target is 0.06 CAD. This implies a price increase of 512% is expected in the next year compared to the current price of 0.01.
DN.CA Groups
Sector & Classification
DN.CA Financial Highlights
Over the last trailing twelve months DN.CA reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 46.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.91% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
DN.CA Ownership
DN.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.23 | 2.772B | ||
| CRON | CRONOS GROUP INC | 39.18 | 1.338B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.066B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 5.17 | 904.914M | ||
| GUD | KNIGHT THERAPEUTICS INC | 155.29 | 730.324M | ||
| DHT-U | DRI HEALTHCARE TRUST | 3.83 | 671.122M | ||
| WEED | CANOPY GROWTH CORP | N/A | 565.768M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 22.49 | 475.264M | ||
| TSND | TERRASCEND CORP | N/A | 349.699M | ||
| HITI | HIGH TIDE INC | 10.35 | 283.038M | ||
| ACB | AURORA CANNABIS INC | 59.28 | 271.641M | ||
| OGI | ORGANIGRAM GLOBAL INC | 28.16 | 261.773M | ||
| CRDL | CARDIOL THERAPEUTICS INC-A | N/A | 221.245M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About DN.CA
Company Profile
Delta 9 Cannabis, Inc. is a vertically integrated cannabis company, which engages in the production of medical and recreational cannabis products. The company is headquartered in Winnipeg, Manitoba and currently employs 200 full-time employees. The company went IPO on 2004-03-31. The firm operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The firm sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. The company also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. The company is focused on producing and selling cannabis oils, extracts, and derivative products.
Company Info
IPO: 2004-03-31
DELTA 9 CANNABIS INC
PO Box 68096 Osborne Village
Winnipeg MANITOBA R3L 2V9 CA
CEO: John William Arbuthnot
Employees: 200
Phone: 12049975328
DELTA 9 CANNABIS INC / DN.CA FAQ
What does DN do?
Delta 9 Cannabis, Inc. is a vertically integrated cannabis company, which engages in the production of medical and recreational cannabis products. The company is headquartered in Winnipeg, Manitoba and currently employs 200 full-time employees. The company went IPO on 2004-03-31. The firm operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The firm sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. The company also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. The company is focused on producing and selling cannabis oils, extracts, and derivative products.
Can you provide the latest stock price for DELTA 9 CANNABIS INC?
The current stock price of DN.CA is 0.01 CAD.
Does DELTA 9 CANNABIS INC pay dividends?
DN.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of DN stock?
DN.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
On which exchange is DN.CA stock listed?
DN.CA stock is listed on the Toronto Stock Exchange exchange.
What sector and industry does DELTA 9 CANNABIS INC belong to?
DELTA 9 CANNABIS INC (DN.CA) operates in the Health Care sector and the Pharmaceuticals industry.